Gene expression profiling of noninvasive primary urothelial tumours using microarrays

被引:52
作者
Aaboe, M
Marcussen, N
Jensen, KME
Thykjaer, T
Dyrskjot, L
Orntoft, TF [1 ]
机构
[1] Aarhus Univ Hosp Skejby, Dept Clin Biochem, Mol Diagnost Lab, DK-8200 Aarhus, Denmark
[2] Aarhus Univ Hosp, Aarhus Hosp, Inst Pathol, DK-8000 Aarhus, Denmark
[3] Aarhus Univ Hosp Skejby, Dept Urol, DK-8200 Aarhus, Denmark
关键词
bladder cancer; gene expression; DNA microarray; keratin;
D O I
10.1038/sj.bjc.6602813
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
At present, the mechanism leading to bladder cancer is still poorly understood, and our knowledge about early events in tumorigenesis is limited. This study describes the changes in gene expression occurring during the neoplastic transition from normal bladder urothelium to primary Ta tumours. Using DNA microarrays, we identified novel differentially expressed genes in Ta tumours compared to normal bladder, and genes that were altered in high-grade tumours. Among the mostly changed genes between normal bladder and Ta tumours, we found genes related to the cytoskeleton (keratin 7 and syndecan 1), and transcription (high mobility group AT-hook 1). Altered genes in high-grade tumours were related to cell cycle (cyclin-dependent kinase 4) and transcription (jun d proto-oncogene). Furthermore, we showed the presence of high keratin 7 transcript expression in bladder cancer, and Western blotting analysis revealed three major molecular isoforms of keratin 7 in the tissues. These could be detected in urine sediments from bladder tumour patients.
引用
收藏
页码:1182 / 1190
页数:9
相关论文
共 36 条
[1]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[2]   High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis [J].
Barbareschi, M ;
Maisonneuve, P ;
Aldovini, D ;
Cangi, MG ;
Pecciarini, L ;
Mauri, FA ;
Veronese, S ;
Caffo, O ;
Lucenti, A ;
Palma, PD ;
Galligioni, E ;
Doglioni, C .
CANCER, 2003, 98 (03) :474-483
[3]   Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma [J].
Bassily, NH ;
Vallorosi, CJ ;
Akdas, G ;
Montie, JE ;
Rubin, MA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (03) :383-388
[4]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[5]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[6]   A comparison of normalization methods for high density oligonucleotide array data based on variance and bias [J].
Bolstad, BM ;
Irizarry, RA ;
Åstrand, M ;
Speed, TP .
BIOINFORMATICS, 2003, 19 (02) :185-193
[7]  
CAIRNS P, 1993, CANCER RES, V53, P1230
[8]   Genetic and molecular markers of urothelial premalignancy and malignancy [J].
Cordon-Cardo, C ;
Cote, RJ ;
Sauter, G .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 :82-93
[9]   Identifying distinct classes of bladder carcinoma using microarrays [J].
Dyrskjot, L ;
Thykjaer, T ;
Kruhoffer, M ;
Jensen, JL ;
Marcussen, N ;
Hamilton-Dutoit, S ;
Wolf, H ;
Orntoft, TF .
NATURE GENETICS, 2003, 33 (01) :90-96
[10]   Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification [J].
Dyrskjot, L ;
Kruhoffer, M ;
Thykjaer, T ;
Marcussen, N ;
Jensen, JL ;
Moller, K ;
Orntoft, TF .
CANCER RESEARCH, 2004, 64 (11) :4040-4048